Neurol. praxi. 2011;12(6):389-393
Immunosuppressive drugs have been used in the practice for more than fifty years. In treating neurological autoimmune diseases, their
role is irreplaceable. Azathioprine, cyclophosphamide, methotrexate, mycophenolate mofetil, mitoxantrone, cyclosporin A and tacrolimus
have been particularly used; clinical trials with cladribine and teriflunomide are under way. The paper deals with the mechanism
of action, adverse events and therapeutic regimens of individual agents; also covered are the indications of immunosuppressive drugs
in the most common autoimmune diseases. During treatment, it is always necessary to weigh the benefits against risks, monitor the
patient carefully and prevent adverse events.
polymyositis, myasthenia gravis.
Published: December 1, 2011 Show citation